Hydroxyurea and cytarabine will half the white cell count after 2–3 days until a safer level is achieved and can be continued until the diagnosis of CML is confirmed from bone marrow aspirates by detection of the Philadelphia chromosome and/or the BCR::ABL1-rearrangement [118]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.